# Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

> **NCT02493049** · PHASE2 · COMPLETED · sponsor: **University of Calgary** · enrollment: 17 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Domperidone

## Key facts

- **NCT ID:** NCT02493049
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02493049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02493049, "Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02493049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*